Outcome of elexacaftor/tezacaftor/ivacaftor therapy in patients with cystic fibrosis and solid organ transplantation

Matilde B Ørum*, Frederikke F Rönsholt, Majbritt Jeppesen, Elisabeth Bendstrup, Terese L Katzenstein, Peter Ott, Michael Perch, Tacjana Pressler, Tavs Qvist, Søren Jensen-Fangel

*Corresponding author af dette arbejde
7 Citationer (Scopus)

Abstract

We report a case series of four patients with cystic fibrosis (CF) and previous solid organ transplantation (SOT) receiving elexacaftor/tezacaftor/ivacaftor therapy for 6 months or more. Data was collected retrospectively. The treatment was well tolerated and all patients reported subjective improvements.

OriginalsprogEngelsk
TidsskriftPediatric Pulmonology
Vol/bind58
Udgave nummer2
Sider (fra-til)602-605
Antal sider4
ISSN8755-6863
DOI
StatusUdgivet - feb. 2023

Fingeraftryk

Dyk ned i forskningsemnerne om 'Outcome of elexacaftor/tezacaftor/ivacaftor therapy in patients with cystic fibrosis and solid organ transplantation'. Sammen danner de et unikt fingeraftryk.

Citationsformater